QScreen AI Inc. logo

QScreen AI Inc. (PMED)

Delisted
26 Jan 2026
CNSX CNSX
CA$
0. 06
-0
-8.3333%
CA$
12.41M Market Cap
- P/E Ratio
- Div Yield
72,872 Volume
- Eps
CA$ 0.06
Previous Close
Day Range
0.06 0.06
Year Range
0.01 0.09
Want to track PMED and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

PMED Chart

QScreen AI Inc. (PMED) FAQ

What does "Delisted" mean?

QScreen AI Inc. has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

No dividend payments were recorded prior to delisting.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

No stock splits were recorded prior to delisting.

What was the last known trading price?

The stock last traded at CA$0.06 on Jan 26, 2026 before being delisted.

QScreen AI Inc. Profile

Health Care Technology Industry
Healthcare Sector
Sheldon Kales CEO
CNSX Exchange
CA74040N1069 ISIN
CA Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Predictmedix AI Inc. is a forefront artificial intelligence (AI) firm dedicated to the advancement of AI-powered technologies catering primarily to the general workplace health and safety and healthcare industries. The company navigates through these sectors with two principal segments: Workplace Health and Safety, and Healthcare. Originally named Predictmedix Inc., the organization underwent a rebranding to Predictmedix AI Inc. in July 2023, marking a new chapter in its mission to integrate advanced AI into critical health and safety applications. Headquartered in Toronto, Canada, Predictmedix AI Inc. stands as a beacon of innovation in leveraging AI for the betterment of global health standards and workplace safety protocols.

Products and Services

  • Disease Symptom Screening Solutions:
  • This offering from Predictmedix AI Inc. is designed to streamline the preliminary screening process for infectious diseases. Utilizing cutting-edge AI, it assesses individuals for symptoms indicative of a higher likelihood of testing positive for infectious conditions, thus recommending those individuals for further definitive testing, such as rapid COVID tests. This technology aims at enhancing the efficiency and safety of workplaces and public health environments by identifying potential health threats before they become widespread.

  • Impairment Detection Screening Scanners:
  • These advanced scanners are a pivotal component of the company’s Workplace Health and Safety segment. They employ AI algorithms to detect signs of impairment caused by various factors such as drugs, alcohol, or fatigue. The goal is to prevent accidents and ensure a safer working environment by proactively identifying individuals who may not be in the best condition to perform their duties safely.

  • Mental Health Screening Stations:
  • Understanding the critical importance of mental well-being in the workplace and beyond, Predictmedix AI Inc. has developed screening stations aimed at identifying signs of mental health issues. This service allows for early intervention and support for individuals potentially experiencing mental health challenges, emphasizing the company’s dedication to comprehensive health and safety measures.

  • Mobile Wellbeing - Telemedicine Remote Patient Monitoring Platform:
  • The Mobile Wellbeing platform represents Predictmedix AI Inc.’s foray into telemedicine, offering a remote patient monitoring solution that connects patients with healthcare providers regardless of location. This service not only facilitates ongoing management of chronic conditions but also enables real-time health monitoring, thereby extending the reach of healthcare services and ensuring continuous care.

Contact Information

Address: Scotia Plaza
Phone: 647 889 6916